Fatro Expands Turkish Presence with Gunesli Aşı Acquisition

Deal News | Aug 05, 2025 | Osborne Clarke

Fatro Expands Turkish Presence with Gunesli Aşı Acquisition

Fatro S.p.A., an Italian veterinary pharmaceutical giant, has acquired a 51% majority stake in Turkish company Gunesli Aşı, known for its veterinary pharmaceutical production, import, and export. This acquisition strengthens Fatro's strategic presence in the Turkish market, marking a significant move from previous distribution-based operations in the region to direct regional control. The transaction was approved by Turkish authorities, with advisory roles played by Proactiva Strategy M&A as the financial advisor, and legal counsel provided by Osborne Clarke Italy's team and the Istanbul-based law firm Pelister Keki Sarac & Co.

Sectors

  • Pharmaceuticals
  • Veterinary
  • Legal Services

Geography

  • Italy – Fatro S.p.A., the acquiring company, is based in Italy and is expanding its operations internationally.
  • Turkey – The target company, Gunesli Aşı, is based in Turkey, where the acquisition took place, and it represents a strategic market for Fatro.
  • Europe – Fatro is one of the main players in the European veterinary pharmaceutical market, and the transaction extends its influence.

Industry

  • Pharmaceuticals – Fatro S.p.A. and Gunesli Aşı operate in the veterinary pharmaceutical sector, producing and distributing pharmaceutical products for animals.
  • Veterinary – The companies involved are focused on the veterinary sector, specifically in pharmaceuticals for animal health.
  • Legal Services – The transaction required legal advice from Osborne Clarke and Pelister Keki Sarac & Co., highlighting the involvement of the legal services industry in M&A activities.

Financials

    Participants

    NameRoleTypeDescription
    Fatro S.p.A.Acquiring CompanyCompanyAn Italian group in the veterinary pharmaceutical sector and a key player in Europe.
    Gunesli AşıTarget CompanyCompanyA Turkish company specialized in the production, import, and export of veterinary pharmaceutical products.
    Osborne ClarkeLegal AdvisorCompanyProvided legal assistance for the transaction with partners Federico Ferrara, Giuliano Lanzavecchia, and junior associate Matteo Tracanella leading the team.
    Proactiva Strategy M&AFinancial AdvisorCompanyActed as financial advisor to the transaction.
    Pelister Keki Sarac & Co.Legal AdvisorCompanyIstanbul-based law firm that collaborated with Osborne Clarke on legal matters.